Alector Future Growth
Future criteria checks 2/6
Alector is forecast to grow earnings and revenue by 15.4% and 22.5% per annum respectively. EPS is expected to grow by 25% per annum. Return on equity is forecast to be -132.4% in 3 years.
Key information
15.4%
Earnings growth rate
25.0%
EPS growth rate
Biotechs earnings growth | 31.1% |
Revenue growth rate | 22.5% |
Future return on equity | -132.4% |
Analyst coverage | Good |
Last updated | 15 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 208 | -143 | -187 | -166 | 4 |
12/31/2025 | 116 | -129 | -126 | -160 | 9 |
12/31/2024 | 62 | -201 | -154 | -137 | 9 |
12/31/2023 | 97 | -130 | -187 | -184 | N/A |
9/30/2023 | 96 | -141 | -190 | -187 | N/A |
6/30/2023 | 102 | -143 | -194 | -190 | N/A |
3/31/2023 | 126 | -135 | -208 | -204 | N/A |
12/31/2022 | 134 | -133 | -24 | -20 | N/A |
9/30/2022 | 133 | -136 | -25 | -21 | N/A |
6/30/2022 | 301 | 36 | 471 | 473 | N/A |
3/31/2022 | 227 | -29 | 483 | 486 | N/A |
12/31/2021 | 207 | -36 | 295 | 299 | N/A |
9/30/2021 | 198 | -33 | 297 | 300 | N/A |
6/30/2021 | 21 | -212 | -189 | -186 | N/A |
3/31/2021 | 18 | -202 | -190 | -187 | N/A |
12/31/2020 | 21 | -190 | -172 | -167 | N/A |
9/30/2020 | 22 | -169 | -154 | -148 | N/A |
6/30/2020 | 19 | -148 | -144 | -136 | N/A |
3/31/2020 | 23 | -127 | -125 | -108 | N/A |
12/31/2019 | 21 | -105 | -115 | -99 | N/A |
9/30/2019 | 24 | -92 | -102 | -88 | N/A |
6/30/2019 | 28 | -76 | -94 | -82 | N/A |
3/31/2019 | 28 | -62 | -84 | -81 | N/A |
12/31/2018 | 28 | -52 | 126 | 127 | N/A |
9/30/2018 | 22 | -45 | 141 | 143 | N/A |
6/30/2018 | 15 | -39 | 157 | 159 | N/A |
3/31/2018 | 8 | -35 | 170 | 171 | N/A |
12/31/2017 | 4 | -32 | -19 | -18 | N/A |
12/31/2016 | 0 | -15 | N/A | -13 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0Z2 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 0Z2 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 0Z2 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 0Z2's revenue (22.5% per year) is forecast to grow faster than the German market (5.5% per year).
High Growth Revenue: 0Z2's revenue (22.5% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 0Z2 is forecast to be unprofitable in 3 years.